Goldman Sachs Group Inc Bioventus Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Bioventus Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 136,631 shares of BVS stock, worth $915,427. This represents 0.0% of its overall portfolio holdings.
Number of Shares
136,631
Previous 162,412
15.87%
Holding current value
$915,427
Previous $1.49 Million
39.17%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding BVS
# of Institutions
145Shares Held
49.4MCall Options Held
85.1KPut Options Held
13K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$87.2 Million30.91% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$46.5 Million19.48% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.28MShares$35.4 Million1.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$18.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$15.9 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $413M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...